XHKG
0722
Market cap47mUSD
Jul 09, Last price
0.46HKD
1D
2.25%
1Q
1.11%
Jan 2017
-66.54%
IPO
-75.41%
Name
UMP Healthcare Holdings Ltd
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
UMP Healthcare Holdings Limited, an investment firm, delivers a broad spectrum of medical and wellness provisions across Hong Kong, Macau, and mainland China. The company's operations are divided into two main divisions: Corporate Healthcare Solution Services and Clinical Healthcare Services. Its extensive service portfolio encompasses virtual medical support, general family practice, and specialized consultations covering diverse fields like internal medicine, surgery, pediatrics, cardiology, dermatology, ENT, orthopedics, ophthalmology, urology, gastroenterology, endocrinology, and diabetes. Additionally, it provides comprehensive dental services, including implants, cosmetic procedures, periodontal care, and orthodontics, alongside traditional Chinese medicine. The company further extends its offerings to include physiotherapy, addressing muscle strengthening, limb and hand function, and eye-hand coordination. Other key services feature day surgery and endoscopy, advanced diagnostic imaging and laboratory testing, health assessments, visa-required medical examinations, immunization and advisory services, vision correction and optometry, reconstructive and aesthetic surgeries (plastic, head, and neck), dermatological and cosmetic treatments, ongoing chronic disease management, and COVID-19 screening. Furthermore, UMP Healthcare is involved in delivering training and advisory services within the healthcare sector. Its client base includes insurance providers, corporate clients, and individual self-paying patients. The organization maintains a vast network of roughly 1,100 directly owned and partnered service facilities. Established in 1990, UMP Healthcare Holdings Limited has its main offices situated in Central, Hong Kong.
Valuation
Title HKD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2025‑06 | 2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | 2019‑06 | 2018‑06 | 2017‑06 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||